Dr Emily Parker explains the importance of the new RCPCH position statement on air pollution and its relevance to healthcare ...

Professor Xenofon Baraliakos, EULAR president-elect, discusses personalised treatment and other challenges and opportunities ...

Study finds perioperative pembrolizumab plus neoadjuvant chemotherapy in early-stage NSCLC is safe, effective and improves ...

Switching to biosimilars when treating patients with haematological cancers does not increase the risk of adverse events, ...

Professor Antonio Almeida shares plans for his EHA presidency, key takeaways from its Congress and thoughts on clinical ...

A new ESPR survey examines how lung ultrasound is used in NICUs across Europe to better understand how this may be improved.

A new nuclear medicine and molecular radiotherapy suite is streamlining and personalising cancer care, as Professor Jon ...